Literature DB >> 7711426

Limited trypsin proteolysis renders carnitine palmitoyltransferase insensitive to inhibition by malonyl-CoA in patients with muscle carnitine palmitoyltransferase deficiency.

S Zierz1.   

Abstract

Carnitine palmitoyltransferase (CPT) was studied in muscle homogenates of two patients with muscle CPT deficiency heterozygous for the Ser-113 Leu mutation in the CPT II gene. Total CPT activity was normal in both patients but was almost completely inhibited by malonyl-CoA and Triton X-100 whereas in controls 38% and 58% of total activity remained in the presence of malonyl-CoA and Triton X-100, respectively. The addition of 1% Tween 20 abolished about half of the activity in patients but not in controls. Preincubation of muscle homogenate with trypsin slightly increased the total activity and rendered the activity greatly insensitive to inhibition by malonyl-CoA in both patients and controls. The data support the view that in patients with muscle CPT deficiency both CPT I and II are active, but that CPT II is abnormally accessible to inhibition by malonyl-CoA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7711426     DOI: 10.1007/bf00577735

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  17 in total

1.  Insights into the topography of mitochondrial carnitine palmitoyltransferase gained from the use of proteases.

Authors:  J D McGarry; N F Brown; P P Inthanousay; D I Park; B A Cook; D W Foster
Journal:  Prog Clin Biol Res       Date:  1992

2.  Malonyl-CoA inhibits proteolysis of carnitine palmitoyltransferase.

Authors:  K Kashfi; G A Cook
Journal:  Biochem Biophys Res Commun       Date:  1991-07-31       Impact factor: 3.575

3.  Carnitine palmitoyltransferase (CPT2) from liver mitochondrial inner membrane becomes inhibitable by malonyl-CoA if reconstituted with outer membrane malonyl-CoA binding protein.

Authors:  I Ghadiminejad; E D Saggerson
Journal:  FEBS Lett       Date:  1990-09-03       Impact factor: 4.124

4.  Proteinase treatment of intact hepatic mitochondria has differential effects on inhibition of carnitine palmitoyltransferase by different inhibitors.

Authors:  K Kashfi; G A Cook
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

5.  Inter-tissue and inter-species characteristics of the mitochondrial carnitine palmitoyltransferase enzyme system.

Authors:  K F Woeltje; V Esser; B C Weis; W F Cox; J G Schroeder; S T Liao; D W Foster; J D McGarry
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

6.  Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long- and short-chain acylcarnitine and acyl-coenzyme A.

Authors:  S Zierz; S Neumann-Schmidt; F Jerusalem
Journal:  Clin Investig       Date:  1993-10

7.  Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane.

Authors:  M S Murthy; S V Pande
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

8.  A proportion of rat liver mitochondrial carnitine palmitoyltransferase can be made activatable by malonyl-CoA.

Authors:  I Ghadiminejad; D Saggerson
Journal:  Biochim Biophys Acta       Date:  1991-10-01

9.  Biochemical evidence for heterozygosity in muscular carnitine palmitoyltransferase deficiency.

Authors:  S Zierz; R R Mundegar; F Jerusalem
Journal:  Clin Investig       Date:  1993-12

10.  Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients.

Authors:  F Taroni; E Verderio; F Dworzak; P J Willems; P Cavadini; S DiDonato
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

View more
  3 in total

1.  Abbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblasts.

Authors:  Min Yao; Min Cai; Dengfu Yao; Xi Xu; Rongrong Yang; Yuting Li; Yuanyuan Zhang; Hiroshi Kido; Dengbing Yao
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 2.  Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.

Authors:  Diana Lehmann; Leila Motlagh; Dina Robaa; Stephan Zierz
Journal:  Int J Mol Sci       Date:  2017-01-03       Impact factor: 5.923

3.  Stabilization of the thermolabile variant S113L of carnitine palmitoyltransferase II.

Authors:  Leila Motlagh; Ralph Golbik; Wolfgang Sippl; Stephan Zierz
Journal:  Neurol Genet       Date:  2016-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.